These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8061849)

  • 41. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of enalapril on left ventricular hypertrophy in patients with mild or moderate essential hypertension].
    Batlouni M; Armaganijan D; Assef JE
    Arq Bras Cardiol; 1990 May; 54(5):347-50. PubMed ID: 2149633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Spirapril in the therapy of mild and moderately severe hypertension. A Czech and Slovak multicenter study].
    Widimský J; Lánská V; Hulínský V
    Vnitr Lek; 1995 Nov; 41(11):744-52. PubMed ID: 8553592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension.
    Oki T; Fukuda N; Iuchi A; Tabata T; Sasaki M; Kawahara K; Ishimoto T; Tominaga T; Okushi H; Fujimoto T; Ito S
    J Card Fail; 1995 Dec; 1(5):365-70. PubMed ID: 12836711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of acute and chronic angiotensin converting enzyme inhibition by spirapril on cardiovascular regulation in essential hypertensive patients. Assessment by spectral analysis and haemodynamic measurements.
    Veerman DP; Douma CE; Jacobs MC; Thien T; Van Montfrans GA
    Br J Clin Pharmacol; 1996 Jan; 41(1):49-56. PubMed ID: 8824693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of spirapril on remodeling of the heart in patients with mild and moderate arterial hypertension].
    Beraia MM; Petriĭ VV; Sergushkina NG; Makolin VI
    Kardiologiia; 2007; 47(4):51-3. PubMed ID: 18260839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
    J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril.
    Oren S; Grossman E; Frohlich ED
    Am J Cardiol; 1996 Jan; 77(1):93-6. PubMed ID: 8540468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term and strict blood pressure lowering by imidapril reverses left ventricular hypertrophy in patients with essential hypertension: an evaluation using a novel indicator of burden on the left ventricle.
    Takahashi M; Minatoguchi S; Nishigaki K; Kawasaki M; Arai M; Uno Y; Fujiwara H
    Hypertens Res; 2006 Feb; 29(2):89-94. PubMed ID: 16755142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of regression of left ventricular hypertrophy after antihypertensive therapy. Comparative echo-Doppler study of ace inhibitors and calcium antagonists].
    Totteri A; Scopelliti G; Campanella G; Bertini M; Castro R; Pintus G; Jommi E
    Minerva Cardioangiol; 1993 Jun; 41(6):231-7. PubMed ID: 8361609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC; El Aouar LM; Mill JG
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment.
    González-Juanatey JR; Pose Reino A; García Acuña JM; Castelo Fuentes V; Amaro Gendón A; Calvo Gómez C; Gil de la Peña M
    Eur Heart J; 1995 Dec; 16(12):1981-7. PubMed ID: 8682036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of blood pressure reduction with trandolapril and enalapril on left ventricular hypertrophy and exercise tolerance.
    Leonetti G; Fogari R; Mazzola C; Pasotti C; Ponti GB; Marelli C; Zanchetti A
    J Hypertens Suppl; 1993 Dec; 11(5):S356-7. PubMed ID: 8158420
    [No Abstract]   [Full Text] [Related]  

  • 56. Relationship between the regression of left ventricular hypertrophy and the changes in circadian blood pressure after long-term treatment with enalapril in hypertensive patients.
    Horio T; Kohno M; Yasunari K; Murakawa K; Yokokawa K; Ikeda M; Fukui T; Kano H; Takeda T
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):177-82. PubMed ID: 8032577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac effects of trandolapril in hypertension.
    Guller B; Hall J; Reeves RL
    Am Heart J; 1993 May; 125(5 Pt 2):1536-41. PubMed ID: 8480626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril].
    Pavliukova EN; Bakhmet'eva TA; Puzyrev KV; Karpov RS
    Kardiologiia; 2006; 46(9):19-25. PubMed ID: 17047618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical application of spirapril in patients with arterial hypertension combined with chronic obstructive pulmonary disease].
    Barbarash OL; Smakotina SA; Kondrikova NV
    Kardiologiia; 2006; 46(8):14-7. PubMed ID: 17047595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Advantages of long-term controlled stepwise therapy of arterial hypertension with the use of angiotensin converting enzyme inhibitor spirapril].
    Katel'nitskaia LI; Ivanchenko DN; Khansheva LA; Kholoshina LV; Glova SE; Pleskachev SA
    Kardiologiia; 2006; 46(3):35-8. PubMed ID: 16710253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.